trimethaphan has been researched along with Cardiac Septal Defect in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
BERGOUIGNAN, F; LENEGRE, J; RENAIS, J; SCEBAT, L | 1 |
Brusan, LA; Panichkin, IuV; Shubin, MK | 1 |
2 other study(ies) available for trimethaphan and Cardiac Septal Defect
Article | Year |
---|---|
[INDICATIONS AND RESULTS OF SURGICAL TREATMENT OF INTERVENTRICULAR COMMUNICATIONS WITH MARKED PULMONARY ARTERIAL HYPERTENSION].
Topics: Cardiac Surgical Procedures; Heart Septal Defects; Heart Septal Defects, Ventricular; Humans; Hypertension; Hypertension, Pulmonary; Mortality; Oxygen; Preoperative Care; Thoracic Surgery; Trimethaphan; Vascular Resistance | 1964 |
[Effect of arfonad on hemodynamics of patients with septal heart defects].
Topics: Cardiac Catheterization; Heart; Heart Septal Defects; Hemodynamics; Humans; Pulmonary Circulation; Trimethaphan | 1974 |